Literature DB >> 22283455

High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease.

B Bilir1, Z Yapici, C Yalcinkaya, I Baris, C M B Carvalho, M Bartnik, B Ozes, M Eraksoy, J R Lupski, E Battaloglu.   

Abstract

Pelizaeus-Merzbacher disease is an early onset dysmyelinating leukodystrophy. About 80% of PMD cases have been associated with duplications and mutations of the proteolipid protein 1 (PLP1) gene. Pelizaeus-Merzbacher-like disease is a genetically heterogeneous autosomal recessive disease and rarely caused by mutations in gap junction protein α12 (GJA12/GJC2) gene. The molecular basis of the disease was investigated in a cohort of 19 Turkish families. This study identified novel chromosomal rearrangements proximal and distal to, and exclusive of the PLP1 gene, showed equal frequencies of PLP1 and GJA12/GJC2 mutations at least in our cohort, and suggested further genetic heterogeneity.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283455      PMCID: PMC3381985          DOI: 10.1111/j.1399-0004.2012.01846.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  31 in total

1.  Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect.

Authors:  Jennifer A Lee; Ricardo E Madrid; Karen Sperle; Carolyn M Ritterson; Grace M Hobson; James Garbern; James R Lupski; Ken Inoue
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

2.  Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease.

Authors:  Jennifer A Lee; Ken Inoue; Sau W Cheung; Chad A Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Hum Mol Genet       Date:  2006-06-14       Impact factor: 6.150

3.  Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination.

Authors:  Nicole I Wolf; Maria Cundall; Paul Rutland; Elisabeth Rosser; Robert Surtees; Sarah Benton; Wui K Chong; Sue Malcolm; Friedrich Ebinger; Maria Bitner-Glindzicz; Karen J Woodward
Journal:  Neurogenetics       Date:  2006-09-13       Impact factor: 2.660

4.  A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease.

Authors:  Leonardo Salviati; Eva Trevisson; Maria Cristina Baldoin; Irene Toldo; Stefano Sartori; Milena Calderone; Romano Tenconi; AnnaMaria Laverda
Journal:  Neurogenetics       Date:  2006-10-10       Impact factor: 2.660

5.  Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations.

Authors:  C Castro; J M Gómez-Hernandez; K Silander; L C Barrio
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.

Authors:  M Bugiani; S Al Shahwan; E Lamantea; A Bizzi; E Bakhsh; I Moroni; M R Balestrini; G Uziel; M Zeviani
Journal:  Neurology       Date:  2006-05-17       Impact factor: 9.910

7.  Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.

Authors:  Daniella Magen; Costa Georgopoulos; Peter Bross; Debbie Ang; Yardena Segev; Dorit Goldsher; Alexandra Nemirovski; Eli Shahar; Sarit Ravid; Anthony Luder; Bayan Heno; Ruth Gershoni-Baruch; Karl Skorecki; Hanna Mandel
Journal:  Am J Hum Genet       Date:  2008-06-19       Impact factor: 11.025

8.  GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.

Authors:  M Henneke; P Combes; S Diekmann; E Bertini; K Brockmann; A P Burlina; J Kaiser; A Ohlenbusch; B Plecko; D Rodriguez; O Boespflug-Tanguy; J Gärtner
Journal:  Neurology       Date:  2007-12-19       Impact factor: 9.910

Review 9.  The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.

Authors:  Karen J Woodward
Journal:  Expert Rev Mol Med       Date:  2008-05-19       Impact factor: 5.600

10.  Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.

Authors:  Catherine Vaurs-Barrière; Marlène Deville; Catherine Sarret; Geneviève Giraud; Vincent Des Portes; José-Maria Prats-Viñas; Giuseppe De Michele; Bernard Dan; Angela F Brady; Odile Boespflug-Tanguy; Renaud Touraine
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more
  4 in total

1.  Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.

Authors:  Elena Georgiou; Kyriaki Sidiropoulou; Jan Richter; Christos Papaneophytou; Irene Sargiannidou; Alexia Kagiava; Georg von Jonquieres; Christina Christodoulou; Matthias Klugmann; Kleopas A Kleopa
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

2.  GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease.

Authors:  Leo Gotoh; Ken Inoue; Guy Helman; Sara Mora; Kiran Maski; Janet S Soul; Miriam Bloom; Sarah H Evans; Yu-Ichi Goto; Ljubica Caldovic; Grace M Hobson; Adeline Vanderver
Journal:  Mol Genet Metab       Date:  2013-12-16       Impact factor: 4.797

3.  Distinct patterns of complex rearrangements and a mutational signature of microhomeology are frequently observed in PLP1 copy number gain structural variants.

Authors:  Vahid Bahrambeigi; Xiaofei Song; Karen Sperle; Christine R Beck; Hadia Hijazi; Christopher M Grochowski; Shen Gu; Pavel Seeman; Karen J Woodward; Claudia M B Carvalho; Grace M Hobson; James R Lupski
Journal:  Genome Med       Date:  2019-12-09       Impact factor: 11.117

Review 4.  Emerging cellular themes in leukodystrophies.

Authors:  Joseph C Nowacki; Ashley M Fields; Meng Meng Fu
Journal:  Front Cell Dev Biol       Date:  2022-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.